About the Measles Session
Measles is a highly contagious disease caused by a virus of the same name. It is characterized by a red rash that spreads across the body, along with other symptoms such as fever, runny nose, reddened eyes, and a cough. The measles virus is mainly spread through respiratory droplets (coughs and sneezes) of an infected person. People who have been exposed to the virus can develop a rash up to three weeks later. The virus can cause complications such as pneumonia, encephalitis, and even death in people with weakened immune systems. It is particularly dangerous in children and pregnant women, as it can lead to birth defects and potentially death. Fortunately, due to the widespread use of the measles vaccination, the number of cases of measles has drastically declined; however, outbreaks still occur. Dermatologists play an important role in diagnosing and managing cases of measles. Early recognition of the characteristic rash is key in diagnosing measles; the rash often appears and spreads quickly across the body. Dermatologists may also be consulted for the management of any ongoing dermatological complications associated with the disease. In an effort to contain the spread of measles, dermatologists should be aware of any ongoing outbreaks in their area and educate patients on proper hand hygiene and the benefits of the measles vaccine. Furthermore, healthcare providers should be prepared to address any questions or concerns related to the disease. Although measles is a highly contagious virus, it is usually treatable with supportive care and prompt identification. With proper education and preventive measures, the number of measles cases can be drastically reduced. Dermatologists play an important role in the identification, treatment, and prevention of measles.
Featured Speakers — Measles 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Measles Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IDC 2027
Why Attend the Measles Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Measles work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Measles research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same programme, same certificate.
Join IDC 2027 for the Measles track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Measles Conference 2027 — FAQs
What is the Measles track at IDC 2027?
The Measles track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Measles. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Measles sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Measles are all welcome — whether presenting or attending.
Can I present my research in the Measles track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Measles sessions?
Yes. IDC 2027 is a hybrid conference — attend the Measles track in person in Rome or join live online, with on-demand access afterward.
Join the IDC 2027 delegation
Rome · June 21–23, 2027 · Hybrid · in-person & virtual
Attend without presenting.

